FFO
PLSE icon

Fortitude Family Office’s Pulse Biosciences PLSE Stock Holding History

Fortitude Family Office’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40
Closed -$864 – 2358
2026
Q1 		$864 Buy
+40
New +$738 ﹤0.01% 1549

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fortitude Family Office's PLSE Position: Q2 2026 in Review

Fortitude Family Office sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 40 shares — an estimated $864 sold.

Fortitude Family Office first reported a position in PLSE in Q1 2026 and held it in 1 quarter. The position peaked at $864 in Q1 2026. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Fortitude Family Office reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 40 Pulse Biosciences shares in Q2 2026, an estimated $864.
  • Fortitude Family Office first reported a position in Pulse Biosciences in Q1 2026 and held it in 1 quarter.
  • Fortitude Family Office's Pulse Biosciences position peaked at $864 in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.